BDX vs DBD · P/E 34, rev $21.84B vs P/E 28, rev $3.75B
Becton Dickinson and Company (BDX) versus Diebold Nixdorf, Incorporated (DBD) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Not investment advice. Open the BDX and DBD stock pages for the full models.
Not investment advice.